XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Interim Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Dec. 29, 2023
Dec. 30, 2022
Revenue:    
Revenue $ 315,574 $ 334,921
Total revenue 315,574 334,921
Cost of revenue:    
Total cost of revenue 32,060 34,450
Gross profit 283,514 300,471
Operating expenses:    
Research and development 67,033 64,450
Sales and marketing 79,003 82,205
General and administrative 65,166 59,972
Restructuring charges 6,091 (244)
Total operating expenses 217,293 206,383
Operating income 66,221 94,088
Other income/(expense):    
Interest income/(expense), net 9,187 4,797
Other income, net 5,425 1,097
Total other income 14,612 5,894
Income before income taxes 80,833 99,982
Provision for income taxes (13,252) (20,534)
Net income including noncontrolling interest 67,581 79,448
Less: net income attributable to noncontrolling interest (600) (73)
Net income attributable to Dolby Laboratories, Inc. $ 66,981 $ 79,375
Net income per share:    
Basic (in usd per share) $ 0.70 $ 0.83
Diluted (in usd per share) $ 0.69 $ 0.82
Weighted-average shares outstanding:    
Basic (in shares) 95,376 95,905
Diluted (in shares) 97,439 97,047
Cash dividend declared per common share (in dollars per share) $ 0.30 $ 0.27
Cash dividend paid per common share (in dollars per share) $ 0.30 $ 0.27
Licensing    
Revenue:    
Revenue $ 293,767 $ 308,011
Cost of revenue:    
Cost of revenue 15,736 13,359
Products and services    
Revenue:    
Revenue 21,807 26,910
Cost of revenue:    
Cost of revenue $ 16,324 $ 21,091